These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12868452)

  • 1. Magnetic resonance imaging and Hallervorden-Spatz syndrome.
    Trimble M
    CNS Spectr; 2003 Jun; 8(6):420. PubMed ID: 12868452
    [No Abstract]   [Full Text] [Related]  

  • 2. Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene.
    Cossu G; Melis M; Floris G; Hayflick SJ; Spissu A
    J Neurol; 2002 Nov; 249(11):1599-600. PubMed ID: 12532925
    [No Abstract]   [Full Text] [Related]  

  • 3. Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.
    Molinuevo JL; Martí MJ; Blesa R; Tolosa E
    Mov Disord; 2003 Nov; 18(11):1351-3. PubMed ID: 14639680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
    Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J
    N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.
    Álvarez-Córdoba M; Fernández Khoury A; Villanueva-Paz M; Gómez-Navarro C; Villalón-García I; Suárez-Rivero JM; Povea-Cabello S; de la Mata M; Cotán D; Talaverón-Rey M; Pérez-Pulido AJ; Salas JJ; Pérez-Villegas EM; Díaz-Quintana A; Armengol JA; Sánchez-Alcázar JA
    Mol Neurobiol; 2019 May; 56(5):3638-3656. PubMed ID: 30173408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
    Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
    Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
    Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V
    Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).
    Hogarth P; Kurian MA; Gregory A; Csányi B; Zagustin T; Kmiec T; Wood P; Klucken A; Scalise N; Sofia F; Klopstock T; Zorzi G; Nardocci N; Hayflick SJ
    Mol Genet Metab; 2017 Mar; 120(3):278-287. PubMed ID: 28034613
    [No Abstract]   [Full Text] [Related]  

  • 9. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign.
    Renaud DL; Kotagal S
    Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.
    Hayflick SJ; Penzien JM; Michl W; Sharif UM; Rosman NP; Wheeler PG
    Pediatr Neurol; 2001 Aug; 25(2):166-9. PubMed ID: 11551748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of neurodegeneration with brain iron accumulation.
    Gregory A; Hayflick SJ
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):254-61. PubMed ID: 21286947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
    Hayflick SJ
    Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome).
    Hayflick SJ
    J Neurol Sci; 2003 Mar; 207(1-2):106-7. PubMed ID: 12614941
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration?
    Kaul B; Goyal V; Shukla G; Srivastava A; Garg A; Bader B; Danek A; Hayflick S; Behari M
    Neurol India; 2013; 61(2):169-70. PubMed ID: 23644319
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel PANK2 gene mutation in a Persian boy: the first report from Iran.
    Aryani O; Houshmand M; Fatehi F
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1170-2. PubMed ID: 23116688
    [No Abstract]   [Full Text] [Related]  

  • 19. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
    Zhang YH; Tang BS; Zhao AL; Xia K; Long ZG; Guo JF; Westaway SK; Hayflick SJ
    Mov Disord; 2005 Jul; 20(7):819-21. PubMed ID: 15747360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.